The drug developer raised nearly $330m earlier this year according to its IPO filing, with $110m being supplied by SoftBank Vision Fund.

The cloud security platform developer, valued at more than $1bn, is eyeing an offering that will take place after 2019 and give NTT a chance to exit.

The SoftBank, NEC, Salesforce, Mitsui, NGK Spark Plug and Dentsu-backed IoT orchestration software provider is reportedly seeking a valuation higher than $270m in the offering.

AstraZeneca spinoff Viela has raised nearly $390m in funding and has filed for an initial public offering that would also allow 6 Dimensions Capital to exit.

Comcast and Grace Beauty-backed exercise equipment provider Peloton has filed to raise up to $500m in an offering on the Nasdaq Global Select market.

The Alibaba and Foxconn-backed facial-recognition technology developer has filed for an offering that is reportedly set to raise $500m to $1bn.

SoftBank-backed genome medical research tech provider 10x Genomics, previously backed by SoftBank, filed to go public. This may be a notable exit in burgeoning genomics and gene technology space, which has seen much corporate backing in recent years.

IoT management software provider Uhuru plans to file for an offering that would allow Salesforce, Mitsui, SoftBank, NEC and NGK Spark Plug to exit.

SoftBank-backed medical research technology provider 10x Genomics, valued at nearly $1.3bn as of this year, has filed to go public.